Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Erasca, Inc. (ERAS) Cash Flow Statement

Erasca, Inc. (ERAS) generated -$98.0M of operating cash flow over the twelve months to 2026-06-30, spent $59000 on capital expenditure and had free cash flow of -$98.1M, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

ERASErasca, Inc.Follow ERAS — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
5.0B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
11 Nov, in 18 days
LineFY2021
Dec 21
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Operating cash flow-79.6-103.3-101.2-109.4-95.5-98.0
Capital expenditure11.214.61.80.10.1-0.1
Free cash flow-90.8-117.8-103.0-109.5-95.6-98.1
Stock-based compensation8.320.126.227.024.9—

USD millions · SEC XBRL

Erasca, Inc. — questions

What is Erasca, Inc.'s operating cash flow?
-$98.0M over the twelve months to 2026-06-30.
How much does Erasca, Inc. spend on capital expenditure?
$59000 over the twelve months to 2026-06-30.
What is Erasca, Inc.'s free cash flow?
-$98.1M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.

Every figure on this page comes from Erasca, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.